Literature DB >> 7690451

Characterization of endothelial cell amino acid transport systems involved in the actions of nitric oxide synthase inhibitors.

K Schmidt1, P Klatt, B Mayer.   

Abstract

N omega-Substituted analogues of L-arginine have proven useful as specific inhibitors of nitric oxide formation in various biological systems. In the present study we describe the characteristics of amino acid transporters that mediate uptake of N omega-methyl-L-arginine (L-NMA) and N omega-nitro-L-arginine (L-NNA) into cultured porcine aortic endothelial cells. The transport of L-[14C]NMA showed biphasic kinetics, with Km values of 4 and 368 microM, and was inhibited by L-arginine, L-homoarginine, L-lysine, and L-ornithine but not by L-leucine or L-isoleucine. Similar transport kinetics (Km values of 6 and 609 microM) and substrate specificities were obtained for L-[3H]arginine uptake, indicating that L-arginine and L-NMA are transported by the same system. In contrast to L-arginine and L-NMA transport, uptake of L-[3H]NNA was monophasic (Km = 617 microM) and was inhibited by L-leucine and L-isoleucine but not by L-arginine, L-homoarginine, L-NMA, L-lysine, or L-ornithine. Uptake studies with L-[3H]leucine revealed that the transport of this amino acid occurred in a manner very similar to that of L-[3H]NNA transport, suggesting that the uptake of both compounds may be mediated by the same system. In additional experiments, we determined the effects of L-NMA and L-NNA on the A23187-induced accumulation of intracellular cGMP, to establish to what extent these transport systems are involved in the actions of nitric oxide synthase inhibitors. L-Lysine and L-ornithine, which both inhibited L-NMA uptake, increased the IC50 of L-NMA from 7.8 microM to 57 microM but did not reduce the inhibitory effects of L-NNA. In the presence of L-leucine or L-isoleucine, however, which both inhibited L-NNA uptake, the IC50 of L-NNA was increased from 1.2 microM to 37 microM but the inhibitory actions of L-NMA remained unaffected. These data demonstrate that the endothelial transport systems for L-arginine and L-leucine mediate the biological effects of L-NMA and L-NNA, respectively.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7690451

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  18 in total

Review 1.  Neuronal nitric oxide synthase and Hepatic Encephalopathy.

Authors:  V L Rao; R F Butterworth
Journal:  Metab Brain Dis       Date:  1998-09       Impact factor: 3.584

2.  Na+ - and Cl- -coupled active transport of nitric oxide synthase inhibitors via amino acid transport system B(0,+).

Authors:  T Hatanaka; T Nakanishi; W Huang; F H Leibach; P D Prasad; V Ganapathy; M E Ganapathy
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

3.  Transport of N(G)-nitro-L-arginine across intestinal brush border membranes by Na+ -dependent and Na+-independent amino acid transporters.

Authors:  T Hatanaka; Y Nabuchi; H Ushio
Journal:  Pharm Res       Date:  1999-11       Impact factor: 4.200

4.  Interaction of nitric oxide synthase inhibitors and their D-enantiomers with rat neutrophil luminol dependent chemiluminescence response.

Authors:  M Dikshit; S S Chari; P Seth; R Kumari
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

5.  Regulation of L-arginine transport and nitric oxide release in superfused porcine aortic endothelial cells.

Authors:  R G Bogle; A R Baydoun; J D Pearson; G E Mann
Journal:  J Physiol       Date:  1996-01-01       Impact factor: 5.182

6.  Nitric oxide synthase in human placenta and umbilical cord from normal, intrauterine growth-retarded and pre-eclamptic pregnancies.

Authors:  R A Rutherford; A McCarthy; M H Sullivan; M G Elder; J M Polak; J Wharton
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

7.  Macula densa arginine delivery and uptake in the rat regulates glomerular capillary pressure. Effects of salt intake.

Authors:  W J Welch; C S Wilcox
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

Review 8.  Development of nitric oxide synthase inhibitors for neurodegeneration and neuropathic pain.

Authors:  Paramita Mukherjee; Maris A Cinelli; Soosung Kang; Richard B Silverman
Journal:  Chem Soc Rev       Date:  2014-10-07       Impact factor: 54.564

9.  Inhibition of nitric oxide synthesis by NG-nitro-L-arginine methyl ester (L-NAME): requirement for bioactivation to the free acid, NG-nitro-L-arginine.

Authors:  S Pfeiffer; E Leopold; K Schmidt; F Brunner; B Mayer
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

Review 10.  Arginine metabolism: nitric oxide and beyond.

Authors:  G Wu; S M Morris
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.